For: | Chang YH. Common therapeutic target for both cancer and obesity. World J Biol Chem 2017; 8(2): 102-107 [PMID: 28588753 DOI: 10.4331/wjbc.v8.i2.102] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v8/i2/102.htm |
Number | Citing Articles |
1 |
Bing Han, Louis M. Weiss. Therapeutic targets for the treatment of microsporidiosis in humans. Expert Opinion on Therapeutic Targets 2018; 22(11): 903 doi: 10.1080/14728222.2018.1538360
|
2 |
Tana S. Pottorf, Micaella P. Fagan, Bryan F. Burkey, David J. Cho, James E. Vath, Pamela V. Tran. MetAP2 inhibition reduces food intake and body weight in a ciliopathy mouse model of obesity. JCI Insight 2020; 5(2) doi: 10.1172/jci.insight.134278
|
3 |
Wook Jin. Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications. Cancers 2020; 12(5): 1339 doi: 10.3390/cancers12051339
|
4 |
Andrea Goya Grocin, Wouter W. Kallemeijn, Edward W. Tate. Targeting methionine aminopeptidase 2 in cancer, obesity, and autoimmunity. Trends in Pharmacological Sciences 2021; 42(10): 870 doi: 10.1016/j.tips.2021.07.004
|
5 |
Martin Juhás, Vinod S.K. Pallabothula, Katarina Grabrijan, Martina Šimovičová, Ondřej Janďourek, Klára Konečná, Pavel Bárta, Pavla Paterová, Stanislav Gobec, Izidor Sosič, Jan Zitko. Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1. Bioorganic Chemistry 2022; 118: 105489 doi: 10.1016/j.bioorg.2021.105489
|